Healthfrom24/7 Wall St.3 months agoHims & Hers (HIMS) Down 21% - Is the GLP-1 Gravy Train Over?Hims & Hers Health faces a significant stock drop due to the end of the Ozempic shortage, impacting its compounded drug market.
